Friday, October 22, 9:00am - 10:20am (EDT)
Time zone
am/pm
24h
Suggestions
Your search did not return any results.
TB Alliance is a proud partner of TB-PRACTECAL, a Phase 2/3 adaptive, open-label, non-inferiority, randomized controlled trial examining 6-month treatment regimens for rifampicin-resistant TB sponsored by Médecins Sans Frontières. This virtual Symposia Session will report the initial trial results on Channel 4. Please see the online program for additional details: https://publicprogramme-union2021.web.indrina.com/dailyprogramme/timeslot/6135d65f354a500010d972e6
https://publicprogramme-union2021.web.indrina.com/dailyprogramme/timeslot/6135d65f354a500010d972e6